You can buy or sell SLP and other stocks, options, and ETFs commission-free!
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students.
Shawn M. O'Connor
52 Week High
52 Week Low
Simulations Plus: Q2 Earnings Insights
Shares of Simulations Plus (NASDAQ:SLP) moved higher after the company reported Q2 results. Quarterly Results Earnings per share increased 25.00% over the pas
$0.14 per share
$0.15 per share